Inhaled Drug Could Treat Rare Cystic Fibrosis Mutations

SpliSense can generate a functioning protein to replace one that is defective in 20 percent of cases.
The post Inhaled Drug Could Treat Rare Cystic Fibrosis Mutations appeared first on Zenger News.

Read More